Secondary Logo

Journal Logo

Most Popular Articles

Reduced sexual dysfunction with aripiprazole once-monthly versus paliperidone palmitate: results from QUALIFY

Potkin, Steven G.; Loze, Jean-Yves; Forray, Carlos; More

International Clinical Psychopharmacology. 32(3):147-154, May 2017.

Clinical advances in obsessive-compulsive disorder: a position statement by the International College of Obsessive-Compulsive Spectrum Disorders

Fineberg, Naomi A.; Hollander, Eric; Pallanti, Stefano; More

International Clinical Psychopharmacology. 35(4):173-193, July 2020.

Body dysmorphic disorder: a treatment synthesis and consensus on behalf of the International College of Obsessive-Compulsive Spectrum Disorders and the Obsessive Compulsive and Related Disorders Network of the European College of Neuropsychopharmacology

Castle, David; Beilharz, Francesca; Phillips, Katharine A.; More

International Clinical Psychopharmacology. 36(2):61-75, March 2021.

A randomized, double-blind study comparing the efficacy and safety of trazodone once-a-day and venlafaxine extended-release for the treatment of patients with major depressive disorder

Fagiolini, Andrea; Albert, Umberto; Ferrando, Laura; More

International Clinical Psychopharmacology. 35(3):137-146, May 2020.

The effects of brexpiprazole and aripiprazole on body weight as monotherapy in patients with schizophrenia and as adjunctive treatment in patients with major depressive disorder: an analysis of short-term and long-term studies

Weiss, Catherine; Weiller, Emmanuelle; Baker, Ross A.; More

International Clinical Psychopharmacology. 33(5):255-260, September 2018.

Optimal treatment for obsessive compulsive disorder: a randomized controlled feasibility study of the clinical-effectiveness and cost-effectiveness of cognitive-behavioural therapy, selective serotonin reuptake inhibitors and their combination in the management of obsessive compulsive disorder

Fineberg, Naomi A.; Baldwin, David S.; Drummond, Lynne M.; More

International Clinical Psychopharmacology. 33(6):334-348, November 2018.

The effectiveness and safety of cariprazine in schizophrenia patients with negative symptoms and insufficient effectiveness of previous antipsychotic therapy: an observational study

Rancans, Elmars; Dombi, Zsófia Borbála; Mátrai, Péter; More

International Clinical Psychopharmacology. 36(3):154-161, May 2021.

Social withdrawal as a trans-diagnostic predictor of short-term remission: a meta-analysis of five clinical cohorts

Oliva, Vincenzo; Fanelli, Giuseppe; Kasper, Siegfried; More

International Clinical Psychopharmacology. 37(2):38-45, March 2022.

Proinflammatory and anti-inflammatory biomarkers in schizophrenia and influence of simvastatin on the interleukin-6

Francesconi, Lenise P.; Victorino, André T.; Salah, Iarsan A.; More

International Clinical Psychopharmacology. 34(2):84-88, March 2019.

Effect of sertraline on depression severity and prolactin levels in women with polycystic ovary syndrome: a placebo-controlled randomized trial

Masoudi, Maryam; Ansari, Sahar; Kashani, Ladan; More

International Clinical Psychopharmacology. 36(5):238-243, September 2021.